Magnesium Hydroxide
Dosage & Administration Guidelines
| Species | Route | Dose | Frequency | Duration & Clinical Notes |
|---|---|---|---|---|
| Dog | PO | Antacid: 5-10 mL of 8% suspension (or 200-400 mg/kg) q4-6h; Laxative: 10-30 mL of 8% suspension (or 1-2 g per animal) q24h | q4-6h for antacid; q24h for laxative | Duration: As needed for symptom relief; not for long-term use Notes: Use with caution in patients with renal impairment. For constipation, ensure adequate hydration. |
| Cat | PO | Antacid: 2-5 mL of 8% suspension q4-6h; Laxative: 5-10 mL of 8% suspension q24h | q4-6h for antacid; q24h for laxative | Duration: As needed Notes: Cats are sensitive to magnesium; avoid in renal disease. |
| Horse | PO | Antacid: 100-200 g per animal q12h; Laxative: 500-1000 g per animal q24h | q12h for antacid; q24h for laxative | Duration: As needed Notes: Not a primary treatment for gastric ulcers; use only as adjunct. Monitor for electrolyte imbalances. |
| Cattle | PO | Antacid: 200-400 g per animal q12h; Laxative: 500-1000 g per animal q24h | q12h for antacid; q24h for laxative | Duration: As needed Notes: May be used in rumen acidosis to neutralize excess acid. Ensure adequate hydration. |
| Small Ruminants (sheep, goats) | PO | Antacid: 10-20 g per animal q12h; Laxative: 25-50 g per animal q24h | q12h for antacid; q24h for laxative | Duration: As needed Notes: Use with caution in animals with urinary calculi risk. |
| Rabbit | PO | 1-2 mL of 8% suspension per kg q12h for GI stasis | q12h | Duration: Until GI motility improves Notes: Use only under veterinary supervision; ensure hydration and supportive care. |
| Birds (e.g., psittacines) | PO | 0.1-0.2 mL of 8% suspension per kg q12h | q12h | Duration: As needed Notes: Limited data; use with caution. |
| Reptiles (e.g., tortoises) | PO | 10-20 mg/kg q24h for constipation | q24h | Duration: Until defecation Notes: Ensure adequate hydration and temperature. |
Clinical Indications & Species Uses
- Antacid
- Osmotic laxative
- Antacid for gastric hyperacidity
- Laxative for constipation
- Treatment of dietary magnesium deficiency (rare)
- Antacid for gastric hyperacidity
- Laxative for constipation (less common)
- Antacid for gastric ulcers (adjunctive)
- Laxative for impaction (rarely used)
- Antacid for rumen acidosis (adjunctive)
- Laxative for indigestion
- Antacid for rumen acidosis
- Laxative for constipation
- Laxative for gastrointestinal stasis (uncommon)
- May be used as a laxative in some species
- Laxative for reptiles (e.g., impaction)
Pharmacology & Mechanism of Action
Drug Class: Antacid, Osmotic Laxative | Pharmacological Group: Magnesium-containing compounds
Mechanism of Action: Magnesium hydroxide acts as an antacid by neutralizing gastric acid, forming magnesium chloride and water. As a laxative, it exerts an osmotic effect in the intestinal lumen, drawing water into the bowel, which increases intraluminal pressure and stimulates peristalsis, leading to evacuation. It may also stimulate the release of cholecystokinin, which enhances intestinal motility and fluid secretion.
Pharmacodynamics: The antacid effect is rapid and of short duration, typically lasting 30-60 minutes. The laxative effect occurs within 2-6 hours after oral administration, depending on the dose and species. Magnesium ions are poorly absorbed from the gastrointestinal tract, but the absorbed fraction can cause systemic effects, particularly in patients with renal impairment.
β‘ Pharmacokinetics Summary
Available Formulations & Strengths
Contraindications & Clinical Warnings
- Renal insufficiency or failure
- Hyper-magnesemia
- Intestinal obstruction or perforation
- Appendicitis-like symptoms (in humans; extrapolate to animals)
- Dehydration or electrolyte imbalance
- Concurrent use with other magnesium-containing products
- Use with caution in patients with cardiac disease, as magnesium can affect cardiac conduction.
- Prolonged use may lead to hypermagnesemia, especially in renal impairment.
- May interfere with absorption of other drugs; separate administration by at least 2 hours.
- In food animals, observe withdrawal times.
- In neonates and young animals, use with caution due to immature renal function.
- Monitor serum magnesium levels in patients on prolonged therapy or with renal disease.
Adverse Effects & Reactions
Common:
- Diarrhea
- Loose stools
- Abdominal cramping
- Nausea (in animals, may manifest as inappetence)
Serious / Severe:
- Hypermagnesemia (with renal impairment)
- Hypotension
- Respiratory depression
- Cardiac arrhythmias
- Muscle weakness
Rare:
- Metabolic alkalosis (with prolonged antacid use)
- Fecal impaction (if inadequate fluid intake)
Key Drug Interactions
| Interacting Drug / Class | Clinical Effect & Mechanism | Severity |
|---|---|---|
| Tetracyclines | Magnesium binds to tetracyclines, reducing their absorption and efficacy. | High |
| Fluoroquinolones | Reduced absorption of fluoroquinolones due to chelation with magnesium. | High |
| Digoxin | Magnesium may affect GI motility, potentially altering digoxin absorption; also, hypomagnesemia can increase digoxin toxicity, but hypermagnesemia may have additive effects on cardiac conduction. | Moderate |
| Iron supplements | Reduced absorption of iron due to chelation. | Moderate |
| Mycophenolate mofetil | Reduced absorption of mycophenolate. | Moderate |
| Corticosteroids | May increase magnesium loss, potentially counteracting the effects. | Mild |
Overdose & Toxicity Management
Signs of Toxicity:
- Diarrhea
- Lethargy
- Muscle weakness
- Hypotension
- Bradycardia
- Respiratory depression
- Coma
- Cardiac arrest
Emergency Treatment Protocol: Discontinue the drug. Provide supportive care including IV fluids to promote renal excretion. In severe cases, administer calcium gluconate IV to antagonize the effects of magnesium. In cases of renal failure, dialysis may be necessary. Monitor serum magnesium levels and cardiac function.
Food Animal Withdrawal Times
Magnesium hydroxide is generally considered to have zero withdrawal times in food animals when used according to label, but extra-label use may require extended withdrawal periods. Consult a veterinarian for specific withdrawal times.
Storage, Handling & Regulatory Information
Storage Temperature: Store at controlled room temperature (15-30Β°C).
Handling & Special Conditions: Keep container tightly closed. Protect from freezing. Shake suspension well before use.
Dispensing Status: Over-The-Counter (OTC)
Approval Status: Not FDA-approved for veterinary use; used off-label.
Extra-Label (Off-Label) Use: In the US, magnesium hydroxide is an OTC product for human use, but in veterinary medicine it may be used extra-label under AMDUCA. For food animals, extra-label use requires a valid veterinarian-client-patient relationship and extended withdrawal times.
Clinical Pearls & Practice Notes
References & Literature
- π Plumb's Veterinary Drug Handbook
- π Papich Veterinary Pharmacology and Therapeutics
- π Compendium of Veterinary Products (CVP)